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Responsiveness of the EuroQoL 5-Dimension (EQ-5D) in Adolescent Idiopathic Scoliosis 
 
ABSTRACT  2 
Purpose: To test the responsiveness of the EuroQoL 5-dimension (EQ-5D) utility scores for adolescent idiopathic scoliosis (AIS).  3 
Methods: A baseline sample of 227 AIS patients was recruited between August and October 2015, and was surveyed prospectively to 4 
9-12 months follow-up. EQ-5D-5L utility scores were derived using a two-step approach: 1) cross-walking from 5-level responses to 5 
3-level responses; and 2) applying the EQ-5D-3L Chinese population value set. An anchor approach was adopted to assess the 6 
responsiveness of EQ-5D. Effect size statistics (standardized effect size and standardized response mean) and independent t-test were 7 
used to assess the responsiveness, as well as to analyze the ability of measures to detect score changes with global health condition 8 
changes or discriminate between the worsened and unchanged/improved groups. 9 
Results: Approximately two-thirds of follow-up patients (64.2%) reported no change in global health condition based on the self-10 
reported health anchor, whilst 4.6% and 31.3% of patients rated worse and better in current health condition compared to baseline, 11 
respectively. In the subgroup where health worsened, EQ-5D utility scores were responsive to detect negative changes. EQ-5D utility 12 
scores had slight improvement in the group where health improved, despite a high mean score of 0.92 at baseline. Neither statistical 13 
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significance nor moderate-large effect size was observed in mean changes among unchanged group. Responsiveness property of the 1 
EQ-5D utility score was generally satisfactory with respect to each health condition group. 2 
Conclusions: EQ-5D is found to be able to capture positive changes, and responsive in detecting important clinical changes in 3 
improved group of AIS population. 4 
 5 
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INTRODUCTION 1 
Adolescent Idiopathic Scoliosis (AIS) is the commonest spine deformity which has no known etiology.[1,2] It is defined as a 2 
lateral curvature of the spine greater than 10 degrees accompanied by vertebral rotation, presenting between 10 and 18 years of age.[3] 3 
Curve progression can occur depending on a number of risk factors, such as the curve magnitude at initial presentation, which is 4 
suggested to be the most important predictor of long-term curve progression and behavior even beyond skeletal maturity.[4] Curve 5 
progression can lead to mental health concerns[5] with subsequent psychological issues and health-compromising behavior.[6] 6 
Interventions like bracing can span the entire pubertal period of these adolescents, and fusion surgery has a long-lasting effect that 7 
persists into adulthood.[7] Assessment of AIS patients’ health-related quality of life (HRQoL) hence is an important factor that 8 
governs the outcome of interventions. In order to fully comprehend and interpret its long-term effect, HRQoL should not only be 9 
captured at a single time-point but also over time to gauge long-term outcomes.  10 
One of the commonly used utility scores is the EuroQoL 5-dimension 5-level (EQ-5D-5L) questionnaire, which is a valid, 11 
reliable and sensitive generic measure to assess the HRQoL in AIS.[8] Despite having been previously validated and found to be an 12 
applicable outcome measure to be used in the local AIS population, the responsiveness of EQ-5D-5L has not been investigated.  13 
Responsiveness refers to the ability of a measure to detect clinically important changes in health over time[9], and hence crucial for 14 
calculating quality-adjusted life-years (QALYs) in cost-utility analyses.[10] Cost-utility assessment of treatment interventions in AIS 15 
is necessary to evaluate long-term outcomes. 16 
 Therefore, we hypothesize that the EQ-5D-5L mapped to the EQ-5D-3L utility scores is responsive to worsened and improved 17 
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health in AIS patients. The aim of this study is to evaluate the responsiveness of the EQ-5D instrument as a utility score for patients 1 
with AIS. This study is based on the global rating of change scale as an anchor, with calculation of effect size statistics among groups 2 
of patients with worsened, unchanged and improved health condition.  3 
 4 
METHODS 5 
This was a prospective study of AIS patients recruited from a scoliosis specialty clinic between August and October 2015. Ethics 6 
was approved by the local institutional review board. Consecutive sampling of AIS patients was performed at the initial visit and these 7 
subjects were surveyed at a follow-up of 9-12 months (between July and August 2016). Exclusion criteria included patients with non-8 
idiopathic scoliosis (congenital/neuromuscular), who were illiterate and refused to participate. Patients who had given consent 9 
completed the EQ-5D-5L questionnaire (Hong Kong (traditional Chinese) EQ-5D-5L version)[11] at baseline in person at the clinic. 10 
The follow-up assessment was carried out in the form of a telephone interview conducted by single research personnel in random 11 
order. At follow-up interview, in addition to the EQ-5D-5L, the global rating of change scale was also completed. Subjects who were 12 
lost to follow-up were marked as defaulted. We planned for at least 50-100 samples as this was classified as good quality of evaluating 13 
responsive property as listed by the COSMIN checklist.[12] 14 
Demographic data of the patients and clinical data at the time of initial visit were collected. All questionnaires were completed 15 
prior to the clinic consultation. The spine surgeon who provided such consultation was unaware of this study and assessed radiographs 16 
as usual. Whole spine standing radiographs (both posteroanterior and lateral) were taken on the same day as the consultation for 17 
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measuring the Cobb angle.[13] Scoliosis curves were classified by the modified Lenke classification[14] which included six curve 1 
types: type 1 (main thoracic), type 2 (double thoracic), type 3 (double major; thoracic curve larger than lumbar curve), type 4 (triple 2 
major), type 5 (thoracolumbar or lumbar curve), and type 6 (double major; thoracolumbar or lumbar curve larger than thoracic curve). 3 
Treatment modalities at initial visit of patients were retrieved from medical records and were recorded as: undergoing observation 4 
management, bracing, bracing followed by surgery and those who had previous fusion surgery undergoing regular review. 5 
 6 
EuroQoL 5-dimension 5-level (EQ-5D-5L) 7 
The EQ-5D-5L has five domain scales (mobility, self-care, usual activities, pain and discomfort, and anxiety and depression) and 8 
five levels for each domain. The EQ-5D-5L has 5 items, each digit in the five digit codes refers to the status of each dimension, 9 
ranging from 1 for no problem, to 5 for severe problem. Since the specific EQ-5D-5L value set / tariff for our country is currently not 10 
available, we adopted a two-step indirect approach to estimate EQ-5D-5L scores similar to another study.[15] The first step was the 11 
application of an indirect interim mapping method.[16] The EQ-5D-5L response values were transformed to the EQ-5D-3L response 12 
values according to the transition probability matrix. Subsequently, the EQ-5D-3L responsive values were scored according to a EQ-13 
5D-3L value set ranging from −0.149 for the worst health status (‘33333’) to 1 for the full health (‘11111’).[17] The visual analogue 14 
scale (VAS) of the EQ-5D, in this case, had been omitted at the follow-up to avoid repetition and confusion, due to the introduction of 15 
the anchor item, which asked the patients to assess their own overall health condition over time.  16 
 17 
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Global Rating of Change Scale 1 
 For this study, an anchor, being an external criterion, was used as the reference to indicate patient improvement or 2 
worsening.[18] As for the AIS population whose cost-utility analysis is usually based on longitudinal follow-up, it is desirable to test 3 
the responsiveness of a transformation of the EQ-5D using an anchor of patient-reported assessment of health change over time (either 4 
prospectively or retrospectively determined) to indicate those for whom change in health occurred.[19]  5 
 The global rating of change (GRC) scale was therefore set as an anchor. GRC is a single-item outcome measure for 6 
independent scoring of self-perceived improvement in a patient, widely used for musculoskeletal research.[20] At the end of the 7 
follow-up assessment following the administration of EQ-5D-5L, GRC scale was administered to ask patients about their overall 8 
health condition as compared to baseline initial visit. The question posed was: “Compared to the first visit (9-12 months ago), how 9 
would you rate your overall health now?”. The response was a 7-point Likert scale: ‘extremely worse’ (rating of -3), ‘worse’ (rating of 10 
-2), ‘a little worse’ (rating of -1), ‘the same’ (rating of 0), ‘a little better’ (rating of +1), ‘better’ (rating of +2), ‘extremely better’ 11 
(rating of +3). Due to insufficient sample size in the three ‘worse’ subcategories, they were collapsed into a single ‘worsened’ 12 
subcategory. Similarly, collapse of three ‘better’ subcategories into a single ‘better’ subcategory was performed. The scale was then 13 
categorized into three meaningful health condition change groups: ‘worsened’ (rating from -3 to -1), ‘unchanged’ (rating of 0), and 14 
‘improved’ (rating from +1 to +3).  15 
 16 
Statistical Analysis 17 
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Differences in baseline characteristics between patients who have followed-up and defaulted were compared using independent t-1 
test and Chi-squared test, where appropriate. These tests were carried out to test the indifference between the follow-up and defaulted 2 
subjects, so to eliminate any concerns of the sampling, response, and selection biases. Descriptive statistics including mean ± standard 3 
deviation (SD), ceiling and floor proportion of the EQ-5D-5L scores at baseline and follow-up assessments were reported.  4 
The responsiveness of the EQ-5D instrument was assessed using the effect size statistics. The utility score difference between 5 
baseline and follow-up assessments were evaluated by standardized effect size (SES) and standardized response mean (SRM) 6 
separately for each group. The standard of SES and SRM was interpreted as trivial for values <0.2, small for values ≥0.2-<0.5, 7 
moderate for values ≥0.5-<0.8, or large for values ≥0.8, according to commonly accepted criteria.[21] The change in health condition 8 
was categorized into meaningful change groups for utility score comparisons.  9 
In order to detect score changes with global health condition changes or discriminate between meaningful change groups, 10 
independent t-tests were performed to compare the utility score in patients with different groups of health condition changes. This 11 
enabled the assessment of the ability of the EQ-5D-5L instrument to match changes in utility score with health, and to discriminate 12 
among three groups of health conditions (worsened vs unchanged/improved; worsened/unchanged vs improved). All statistical 13 
analyses were conducted using STATA version 13.0. A p-value of <0.05 was considered as statistically significant. Multiple testing 14 
with Bonferroni correction was performed. 95% confidence intervals (CIs) were listed when appropriate. 15 
  16 
RESULTS 17 
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The baseline characteristics of all patients are shown in Table 1. Out of a total of 227 patients recruited at baseline, 51 patients 1 
(22.5%) defaulted at follow-up assessment. At baseline, the majority of patients were female (74.9%), of mild or moderate curvature 2 
with Cobb angle of ≤40º (90.3%), and were under observation with regular follow-up (61.2%). For those who were prescribed bracing, 3 
63% had already undergone bracing for at least one year or more. There were no significant differences in the characteristics of those 4 
who followed-up or defaulted except for the duration of bracing. Among the defaulted patients, 72.7% were patients with at least one 5 
year of bracing, who seemed more likely to default than patients with less than one-year bracing (27.3%). However, there were 6 
changes in the responses within each of the five domain scales of the EQ-5D-5L when comparing scores at the follow-up with the 7 
baseline as illustrated in figures 1 and 2.  8 
Baseline and follow-up of EQ-5D-5L utility scores are shown in Table 2. Mean utility scores at baseline and follow-up 9 
assessments were 0.931±0.113 and 0.942±0.091, respectively, with insignificant mean change of 0.003±0.120 over time. There was no 10 
floor effect for the EQ-5D-5L utility score at baseline and follow-up but severe ceiling effects were observed. Table 3 shows 11 
distribution of global rating of change scale. About two-third of follow-up patients (64.2%) reported no change in global health 12 
condition based on the self-reported health anchor, whilst 4.6% and 31.3% of patients rated worse and better in current health 13 
condition compared to baseline, respectively.  14 
Table 4 illustrates the mean changes and effect size statistics for each health condition change group. In the subgroup where 15 
health worsened, EQ-5D-5L utility scores were responsive to detect negative changes. For those with health improvement, EQ-5D-5L 16 
utility scores also had slight improvements despite an already high mean score of 0.92 at baseline. Neither statistical significance nor 17 
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moderate-large effect size was observed with mean change in the unchanged group. Table 5 shows the mean difference in change 1 
between health groups. Mean change over time in the improved group was statistically different from the worsened (P=0.033) and the 2 
worsened/unchanged (P=0.033) groups, whilst significant mean differences between improved/unchanged versus worsened group 3 
(P=0.038) was observed.  4 
Responsiveness property of the EQ-5D-5L utility score was generally satisfactory with respect to all health condition groups. 5 
 6 
DISCUSSION  7 
AIS is the commonest spinal deformity that affects adolescents from puberty until skeletal maturity but the lasting effects of the 8 
disorder can reach adulthood. Hence, with possible interventions spanning a long period of time, decisions for observation (actively 9 
monitoring) versus bracing or surgical interventions may vary over time. There are reports of relative differences in properties among 10 
disease-specific measures such as SRS-7 versus SRS-22 in AIS children who had undergone spinal fusion, including their abilities in 11 
detecting changes in HRQoL measures preoperatively versus 1-year post-operation.[22] Similarly, reports of SRS-22[23] and SRS-12 
30[24] changes 2-years after surgery and at 5-years[25] follow-up have also showed good reflection of HRQoL outcomes. However, it 13 
is still unknown how utility scores can assess the effect of scoliosis and its treatment outcomes on quality of life over time.  14 
 A recent study showed that the SRS-22 scores can be mapped onto EQ-5D-5L utility scores in AIS patients to generate cost-15 
utility data.[26] However, this can only provide individual score sets without responsiveness information. This is the first study, to our 16 
best knowledge, that examines the responsiveness of EQ-5D in the AIS patients. We are in search of a generic instrument which can 17 
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generate utility scores, not only permitting comparison between patient groups,[27] but is essential in cost-utility analyses for 1 
longitudinal cohorts. It is necessary to analyze this tool’s responsiveness and its ability to detect any improvement or worsening in 2 
quality of life. The responsiveness of EQ-5D has been studied in stroke, breast cancer and chronic obstructive pulmonary disease[28-3 
30], however it has not been tested in an AIS population.  4 
In this study, EQ-5D successfully captured positive and negative changes that matches improvement or worsening of health as 5 
suggested by the SES and SRM. Furthermore, the SES was near 0 in the unchanged group verifying its accuracy in detecting change. 6 
The EQ-5D has been found to be reasonably responsive in the worsened group, with SES of 0.71, comparable to that of 0.69 in breast 7 
cancer patients, with both studies adopting a self-rated change in quality of life.[29] Change in EQ-5D utility scores was able to 8 
differentiate between each of the health condition groups derived from the self-reported health anchor, except for comparison between 9 
unchanged and worsened group (P=0.216), as well as between improved and unchanged group (P=0.185). The mean changes in EQ-10 
5D scores were statistically different at a significant level between improved versus worsened, improved versus worsened/unchanged, 11 
and improved/unchanged versus worsened groups. As generic instruments are designed to capture all aspects of HRQoL, they can 12 
provide a broader context by which to interpret the information about change in HRQoL[31] and QALYs in cost-utility analyses. 13 
Current results revealed that the ability of EQ-5D utility scores in detecting deterioration was better than detecting improvement, 14 
leading to the greater extent of QALYs loss in cost-utility analyses.  15 
 It may also be worthwhile to appreciate the changes within the five domain scales of EQ-5D-5L over time. These changes in 16 
various aspects can possibly contribute to the differences in the global health condition scale, given that the follow-up population was 17 
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comprised of very similar characteristics except the 2.5% increase in patients braced less than one year from baseline. The changes in 1 
EQ-5D-5L included the complete diminishing of ‘moderate problems’ in the Mobility, Self-care and Usual Activity domains while an 2 
increased proportion of patients shifted from ‘moderate problem’ to ‘no problem’ in the Anxiety domain, despite a higher proportion 3 
of both ‘slight problem’ and ‘moderate problem’ with Discomfort. The only aspect worsened was the discomfort at 9-12 months 4 
follow-up, whereas all other aspects had improved. How these 5 domains contributed to the worsened/improved/unchanged general 5 
health condition on the global health scale is of further interest, especially relating to different treatment modalities. The construct of 6 
the 5 domains enables EQ-5D-5L to be more receptive in detecting changes over time. In addition, EQ-5D-5L was able to still detect 7 
changes beyond the already very high ceiling effect at baseline, as reflected by the further increase in ceiling effect by 1.3% in the 8 
follow-up patients. High ceiling effect of EQ-5D-5L dimension might be in part explained by the generic nature of EQ-5D scale. This 9 
must take into consideration the 64.2% of patients who reported ‘the same’ in the global health condition, with a total of 4.6% 10 
reporting ‘a little worse’ or ‘worse’, and a sum of 31.3% with a response of ‘a little better’, ‘better’ or ‘extremely better’.  11 
 The limitations of this study include the use of an indirect interim mapping method for EQ-5D-5L, instead of a direct valuation 12 
approach as the value sets for EQ-5D-5L are still under development.[32] There were contrasting claims however, that data sets 13 
generated by algorithm mapping method were found to be narrower than the time trade-off value sets,[33] whereas another study 14 
based on breast cancer data found a lack of differences including responsiveness of EQ-5D-5L scores by both approaches.[34] 15 
Another limitation was the different modes of conducting the EQ-5D-5L questionnaires at baseline and at follow-up, being filling up 16 
in person versus phone interview respectively. This was due to the timing of follow-up visits not coinciding with the responsiveness 17 
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time-point and it was impractical to recall patients only for the questionnaire. Possible discrepancies between written and verbal 1 
interviews were minimized by having the same research personnel conduct all phone interviews, in a systematic manner by which all 2 
5 levels of responses of the EQ-5D-5L were read out to the subjects before an answer was given. Nevertheless, differential modes of 3 
administration have not been shown to lead to significant differences in EQ-5D scores.[35] Moreover, future study can also be 4 
improved with the use of multiple independent anchors (e.g. clinician-based anchor, proxy-based anchor versus patient-reported 5 
anchor) and to examine and confirm responsiveness across multiple samples. Despite the advantages of GRC scale being simple and 6 
widely used, weaknesses including less reliability and validity of single-item global rating of change scale were pointed out in 7 
previous literature.[20] Of note, this study made prior assumptions that changes in health condition resulted from scoliosis. Variations 8 
in EQ-5D-5L utility scores may not fully represent changes in health condition as a direct result of scoliosis. There may also be 9 
variations with different types of scoliosis and ethnic groups which require further study. Nonetheless, this study has shown that the 10 
EQ-5D is successful in detecting changes in health of an AIS population, and can serve as the basis of larger sample-sized, 11 
longitudinal study in the AIS population in the future to detect any significant changes over time for treatment modality in details, as 12 
well as to detect long-term outcomes. 13 
 14 
CONCLUSION 15 
The EQ-5D utility score is found to be able to capture positive changes in HRQoL score in AIS patients, and responsive in 16 
detecting important clinical changes in improved group of scoliosis population. Future studies about responsiveness property of EQ-17 
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5D score with respect to health state deterioration are warranted.  1 
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Figure Legends 1 
Figure 1: The 5-level response distribution (%) of five domains in EQ-5D-5L at baseline.  2 
 3 
Figure 2: The 5-level response distribution (%) of five domains in EQ-5D-5L at 9 – 12 months follow-up. At follow-up, response 4 
‘Moderate problem’ (in light green) completely diminished in the domains Mobility, Self-care and Usual Activities, whereas increase 5 
in responses ‘Slight problem’ and ‘Moderate problem’ in Discomfort was noted.  6 
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Figure 1 1 
 2 
Figure 2 3 
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Table 1. Baseline Characteristics of Adolescent Idiopathic Scoliosis Patients who complete and did not complete assessment at follow-up 1 
    Baseline (N=227)   Follow-up (N=176)   Default (N=51) 
Characteristics N % EQ-5D-5L score (Mean±SD) 
 
N % EQ-5D-5L score (Mean±SD) 
 
N % 
Age (years, Mean±SD) 15.6 ± 4.5   15.8 ± 4.9   14.8 ± 2.3 
 
<18 193 85.0 % 0.927 ± 0.118  145 82.4 % 0.933 ± 0.112  48 94.1 % 
 
≥18 34 15.0 % 0.957 ± 0.071  31 17.6 % 0.961 ± 0.071  3 5.9 % 
Gender           
 
Male 57 25.1 % 0.939 ± 0.104  45 25.6 % 0.954 ± 0.085  12 23.5 % 
 
Female 170 74.9 % 0.929 ± 0.116  131 74.4 % 0.937 ± 0.093  39 76.5 % 
Cobb Angle (Mean±SD) 25.0 ± 11.4   25.2 ± 11.4   24.6 ± 11.8 
 
≤40° (Mild or moderate) 205 90.3 % 0.934 ± 0.112  159 90.3 % 0.944 ± 0.091  46 90.2 % 
 
>40° (Severe) 22 9.7 % 0.912 ± 0.123  17 9.7 % 0.917 ± 0.097  5 9.8 % 
Treatment modality           
 
Observation with regular follow-up 139 61.2% 0.961 ± 0.069  104 59.1% 0.947 ± 0.085  35 68.6% 
 
Braced before 13 5.7 % 0.974 ± 0.067  12 6.8 % 0.915 ± 0.128  1 2.0 % 
 
Bracing 54 23.8 % 0.874 ± 0.146  43 24.4 % 0.926 ± 0.099  11 21.6 % 
 
Surgery 21 9.3% 0.860 ± 0.175  17 9.7% 0.966 ± 0.078  4 7.8% 
Duration of bracing           
 
<1 year 20 37.0 % 0.815 ± 0.145  17 39.5 % 0.935 ± 0.090  3 27.3 % 
 
≥1 year 34 63.0 % 0.908 ± 0.137  26 60.5 % 0.921 ± 0.105  8 72.7 % 
Modified Lenke Classification            
 
Type 1 63 27.8 % 0.918 ± 0.135  46 26.1 % 0.915 ± 0.089  17 33.3 % 
 
Type 2 23 10.1 % 0.922 ± 0.102  19 10.8 % 0.919 ± 0.107  4 7.8 % 
 
Type 3 41 18.1 % 0.941 ± 0.124  34 19.3 % 0.955 ± 0.086  7 13.7 % 
 
Type 4 11 4.9 % 0.962 ± 0.085  5 2.8 % 0.949 ± 0.070  6 11.8 % 
 
Type 5 38 16.7 % 0.925 ± 0.106  29 16.5 % 0.965 ± 0.085  9 17.7 % 
 
Type 6 51 22.5 % 0.944 ± 0.088  43 24.4 % 0.953 ± 0.093  8 15.7 % 
                        
N = number of subjects; SD = Standard deviation; EQ-5D-5L = EuroQol Five Dimensions Five-level 2 
Table 2. Descriptive statistics of EQ-5D-5L utility score at baseline and follow-up 
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 Mean 
Standard 
deviation Observed Range Theoretical Range Floor (%) Ceiling (%) 
EQ-5D-5L             
Baseline 0.931 0.113 0.339-1.000 -0.149-1.000 0% 65.6% 
Baseline* 0.939 0.106 0.505-1.000 -0.149-1.000 0% 69.7% 
Follow-up 0.942 0.091 0.610-1.000 -0.149-1.000 0% 66.9% 
Mean Change 0.003 0.120         
EQ-5D-5L = EuroQol Five-Dimensions Five-level 1 
Note: 2 
*Baseline descriptive statistics of respondents who have completed both baseline and follow-up 3 
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Table 3. Distribution of global rating of change scale 
 
      
Response 
 
Follow-up (n=176) 
    N % 
-3 extremely worse 0 0.0 % 
-2 worse 1 0.6 % 
-1 a little worse 7 4.0 % 
0 same 113 64.2 % 
1 a little better 20 11.4 % 
2 better 18 10.2 % 
3 extremely better 17 9.7 % 
 1 
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Table 4. Mean Change, Standardized Effect Size and Standardized Response Mean of EQ-5D-5L Utility Scores by Global Rating of 1 
Change Scale 2 
  
Mean (±SD) 
at baseline 
Mean (±SD) 
at 6-month 
follow-up 
Mean 
Change 
(±SD)† 
p-value SES (95% CI) SRM (95% CI) 
Worsened group (n = 8) 0.92±0.12 0.84±0.14 -0.08±0.21 0.299 -0.71 (-1.81,0.43) -0.40 (-1.02,0.24) 
Unchanged group (n = 113) 0.95±0.09 0.95±0.09 -0.01±0.10 0.579 -0.06 (-0.25,0.15) -0.05 (-0.23,0.13) 
Improved group (n=54) 0.92±0.13 0.95±0.09 0.03±0.13 0.093 0.25 (-0.01,0.57) 0.23 (-0.01,0.54) 
SES=standardized effect size; SRM=standardized response mean; CI = Confidence Interval; SD=standard deviation 3 
Note: 4 
† Higher scores represents a higher level of functioning or a better HRQOL 5 
 6 
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Table 5. Mean difference in change of EQ-5D-5L utility scores with 95% confidence interval on discriminating groups of global health 1 
condition 2 
  Mean difference in change (95% CI) p-value 
Unchanged - worsened group† 0.08 (-0.026 - 0.182) 0.216 
Improved - worsened group† 0.11* (0.007 - 0.222) 0.033 
Improved - unchanged group† 0.04 (-0.010 - 0.084) 0.185 
Improved - worsened/unchanged group  0.04* (0.004 - 0.080) 0.033 
Improved/unchanged – worsened group 0.09* (0.005 - 0.174) 0.038 
CI = Confidence Interval 3 
Note: 4 
*Significant difference between groups with p-value < 0.05 5 
†Tested by Bonferroni correction 6 
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Table 6. Factors associated with change in EQ-5D-5L utility scores by multiple linear regressions 1 
Factor† 
Change in EQ-5D-5L score 
(n = 175) 
Coeff. 95%CI p-value 
Age, year -0.004 (-0.008,0.000) 0.072 
Female (vs. Male) -0.028 (-0.068,0.012) 0.165 
Cobb Angle 0.001 (-0.001,0.002) 0.434 
Treatment modality (vs. Observation with regular follow-up) 
Braced before -0.030 (-0.104,0.044) 0.424 
Bracing 0.062* (0.020,0.105) 0.004* 
Surgery 0.103* (0.041,0.164) 0.001* 
Modified Lenke Classification (vs. Type 1)    
Type 2 -0.008 (-0.071,0.054) 0.793 
Type 3 -0.005 (-0.057,0.047) 0.851 
Type 4 0.036 (-0.072,0.143) 0.513 
Type 5 0.042 (-0.012,0.097) 0.127 
Type 6 0.012 (-0.037,0.061) 0.623 
        
EQ-5D-5L = EuroQol Five-Dimensions Five-level; CI = Confidence Interval; Coeff = Coefficient 2 
Notes: 3 
*Significant with p-value < 0.05 4 
†Variable in brackets is the reference category for independent variables 5 
 6 
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